European-Asian private equity firm AGIC Capital has held the final closing of its second fund, AGIC Fund II, which will be focused on advanced industrial and medical technology investments. AGIC Fund II raised $1.2 billion, reflecting a strong investor appetite for funds with distinctive investment strategies and innovative, differentiated approaches to post-investment value creation. It targets majority and significant minority investments with enterprise values typically in the range of $50–500 million.
Founded in 2015 by capital market veteran Henry Cai, AGIC Capital’s debut $1 billion fund made seven buyout and growth-stage investments, mostly in Europe, and has successfully exited three investments to date with good returns.
Henry Cai, Founding Partner of AGIC based in Hong Kong, says: “The strong performance of AGIC Fund I proves that our strategy of supporting portfolio companies in their international expansion is highly effective and resilient even during times of unusual stress. We will continue to focus on supporting our companies with our complementary resources and know-how.”
Heiko von Dewitz, Partner of AGIC based in Munich, says: “While AGIC’s target investment sectors continue to benefit from strong long-term tailwinds, our deep technology and domain expertise allows us to early spot emerging technology and industry trends and identify promising investment targets. This will remain another key success factor for AGIC going forward.”
